Skip to main content
OpenTrials

Clinical trial condition

Neuroectodermal Tumors

Explore clinical trials studying Neuroectodermal Tumors. Study availability and eligibility vary by location and protocol.

5,995 public trials 1,209 recruiting studies
Refine in advanced search Browse all conditions

Neuroectodermal Tumors trial results

Active, Not Recruiting

A Single-arm Trial of Atezolizumab/Platinum/Etoposide for the Treatment of Advanced Large-cell Neuroendocrine Cancer of the Lung

NCT05470595

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Neuroendocrine, +14 more
Locations
  • Charité - Universitätsklinikum Berlin Centrum 12, Medizinische Klinik Berlin, Germany
  • Evangelische Lungenklinik Berlin, Germany
  • Klinikum der Universität zu Köln, Klinik I für Innere Medizin Cologne, Germany
  • Universitätsklinikum Dresden, Medizinische Klinik 1 Dresden, Germany
View all 15 locations
View Trial Details
Active, Not Recruiting

A Study of Berubicin in Adult Subjects With Recurrent Glioblastoma Multiforme

NCT04762069

Conditions
Astrocytoma, Brain Diseases, Brain Neoplasms, +15 more
Locations
  • University of Arkansas Little Rock, Arkansas, United States
  • Southern California Permanente Medical Group Los Angeles, California, United States
  • University of California Irvine Orange, California, United States
  • University of Califonia San Diego Moores Cancer Center San Diego, California, United States
View all 48 locations
View Trial Details
Active, Not Recruiting

Vorinostat in Treating Patients With Metastatic Melanoma of the Eye

NCT01587352

Conditions
Eye Diseases, Eye Neoplasms, Melanoma, +13 more
Locations
  • NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center New York, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
  • Vanderbilt University/Ingram Cancer Center Nashville, Tennessee, United States
View Trial Details
Active, Not Recruiting

UK ENcorafenib and BInimetinib Real-world Study in Melanoma

NCT07022457

Conditions
Melanoma, Metastatic Melanoma, BRAF V600 Mutation Positive, Neoplasms, +10 more
Locations
  • Southend University Hospital Westcliff-on-Sea, Essex, United Kingdom
  • Queen Elizabeth Hospital Birmingham, United Kingdom
  • Addenbrookes Hospital Cambridge, United Kingdom
  • University Hospital Coventry and Warwickshire Coventry, United Kingdom
View Trial Details

Related conditions